You are here

  • Home
  • Archive
  • Volume 74, Issue 2
  • Immunogenicity, adalimumab levels and clinical response in ankylosing spondylitis patients during 24 weeks of follow-up

Article metrics

Article menu
Download PDFPDF
Clinical and epidemiological research
Extended report
Immunogenicity, adalimumab levels and clinical response in ankylosing spondylitis patients during 24 weeks of follow-up

 

Online download statistics by month:

Online download statistics by month: December 2013 to June 2020

AbstractFullPdf
Dec 201382466158
Jan 20141165267
Feb 2014953945
Mar 2014682031
Apr 2014672430
May 2014633738
Jun 2014332122
Jul 2014621214
Aug 2014491415
Sep 2014613348
Oct 2014351311
Nov 2014411619
Dec 2014291410
Jan 2015115430134
Feb 20155652569
Mar 20153312748
Apr 20151523241
May 20151051222
Jun 2015791617
Jul 2015801723
Aug 2015601620
Sep 2015792116
Oct 2015681112
Nov 2015791216
Dec 2015601220
Jan 201671915
Feb 2016521111
Mar 2016951716
Apr 2016711515
May 2016491514
Jun 2016491413
Jul 20165468
Aug 20165787
Sep 20165597
Oct 201651128
Nov 2016402114
Dec 20163042
Jan 2017301310
Feb 201738134
Mar 2017512214
Apr 20175955
May 201742136
Jun 201760168
Jul 20175044
Aug 2017105128
Sep 2017961410
Oct 201786118
Nov 201710657
Dec 20173522
Jan 20189375
Feb 2018911410
Mar 201893147
Apr 20184355
May 20187532
Jun 20186031
Jul 20189973
Aug 20185263
Sep 20185753
Oct 20188152
Nov 20187552
Dec 20185542
Jan 20196272
Feb 201955113
Mar 20196275
Apr 201973105
May 201943105
Jun 20197753
Jul 201970104
Aug 201953105
Sep 20199841
Oct 201911183
Nov 2019111126
Dec 20196276
Jan 2020138166
Feb 202088153
Mar 20205321
Apr 2020117103
May 20207160
Jun 20206420
Total806910931268